Research Article
[Retracted] Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
Table 1
Comparison of clinical data between two groups (n, %).
| | Group | Single group (n = 85) | Combined group (n = 67) | χ 2 value | value |
| | Gender | | Male | 46 (54.12%) | 34 (50.75%) | 0.171 | 0.679 | | Female | 39 (45.88%) | 33 (49.25%) | | |
| | Age (years) | | < 60 | 37 (43.53%) | 28 (41.79%) | 0.012 | 0.913 | | ≥ 60 | 48 (56.47%) | 39 (58.21%) | | |
| | BMI (kg/m2) | | < 24 | 45 (52.94%) | 49 (63.64%) | 1.897 | 0.168 | | ≥ 24 | 40 (47.06%) | 28 (36.36%) | | |
| | Smoking history | | With | 51 (60.00%) | 37 (55.22%) | 0.351 | 0.554 | | Without | 34 (40.00%) | 30 (44.78%) | | |
| | Course of NSCLC (months) | | < 5 | 66 (77.65%) | 53 (79.10%) | 0.047 | 0.829 | | ≥ 5 | 19 (22.35%) | 14 (20.90%) | | |
| | Pathological type | | Adenocarcinoma | 78 (91.76%) | 59 (88.06%) | 0.578 | 0.447 | | Nonadenocarcinoma | 7 (8.24%) | 8 (11.94%) | | |
| | Number of brain metastases | | | 50 (58.82%) | 36 (53.73%) | 0.395 | 0.529 | | > 3 | 35 (41.18%) | 31 (46.27%) | | |
|
|
